Kodiak Sciences (KOD) Other financing activities (2019 - 2026)
Kodiak Sciences (KOD) posted Other financing activities of $922000.0 for Q1 2026, down 99.47% on a QoQ basis from $172.9 million in Q4 2025, and up 643.55% year-over-year from $124000.0 in Q1 2025.
Kodiak Sciences (KOD) Other financing activities (2019 - 2026) Analysis & Trends
Kodiak Sciences' Other financing activities history runs 8 years deep, the most recent figure standing at $922000.0 for Q1 2026.
- Quarterly Other financing activities rose 643.55% year-over-year to $922000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.8 million (up 89930.05% YoY) and the FY2025 annual result came in at $173.0 million, up 161544.86% from the prior year.
- Other financing activities was $922000.0 for Q1 2026 at Kodiak Sciences, down from $172.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $172.9 million in Q4 2025 and bottomed at -$1.6 million in Q2 2022.
- A 5-year average of $12.6 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities tumbled 104.16% — and 2025, when it soared 360062.5%.
- Kodiak Sciences' Other financing activities stood at $1.7 million in 2022, then sank by 92.85% to $122000.0 in 2023, then plunged by 60.66% to $48000.0 in 2024, then surged by 360062.5% to $172.9 million in 2025, then slumped by 99.47% to $922000.0 in 2026.
- Business Quant data shows KOD's Other financing activities at $922000.0 in Q1 2026, $172.9 million in Q4 2025, and -$42000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 922,000.00 |
| Mar 31, 2026 | 922,000.00 |
| Dec 31, 2025 | 172.88 Mn |
| Dec 31, 2025 | 172.88 Mn |
| Jun 30, 2025 | -42,000.00 |
| Jun 30, 2025 | -42,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Mar 31, 2025 | 124,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Dec 31, 2023 | 122,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Sep 30, 2023 | -71,000.00 |
| Jun 30, 2023 | 122,000.00 |
| Jun 30, 2023 | 122,000.00 |